Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.
Can a drug for type 2 diabetes work for those with type 1? How will a new basal insulin compare to Lantus?
The World Health Organization (WHO) recently released its World Health Statistics 2o12 report, compiling data from 194 countries. The report estimates that about 9% of...
Kelly on 26 years of living with diabetes and “what I wish I had known...”
James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .
In December, Novo Nordisk announced that it will advance FIAsp, an ultra-rapid-acting version of Novolog (insulin aspart), directly into phase 3 trials in late 2013 (the...
Why did Qnexa become Qsymia? diaTribe investigates the thinking behind drug names… and why they’re vital to patient safety.
Many people with diabetes fear eye diseases leading to blindness. In diabetic macular edema (DME), the leading cause of blindness among working-age Americans (over 560,...
On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and Ryzodeg (insulin degludec/aspart). Tresiba is Novo Nordisk’...
A candid interview with diaTribe advisory board member Dr. Anne Peters touches on the newest drugs and devices, curing type 1, and addressing obesity.
Supreme Court Justice Sonia Sotomayor’s incredible journey with type 1 diabetes.
A new study from the University of North Carolina and the Chinese Center for Disease Control (CCDC) has found that diabetes is four times more common among Chinese...
The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.
Adam discovers why sleep is critical to diabetes control.
On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus Pain Management System, designed for the treatment...
The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.
As noted in new now next in diaTribe #37, Novo Nordisk announced in October 2011 that it had submitted its two new “next-generation” insulin products for approval in the...
Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients
On February 7, the FDA cleared LifeScan’s OneTouch VerioSync blood glucose meter. It will feature wireless Bluetooth compatibility with the iPhone, allowing blood...
Kelly reveals how you can help change the truly unacceptable care people with diabetes are receiving in prison.

Pages